Pharmafile Logo

Mastering Outcome vs. Process Control in Remote Work – Building Company Culture Virtually

Struggling to manage your remote pharma teams effectively? Discover the power of outcome control. Learn how trusting your team to achieve results, their way, can lead to greater productivity and a more positive work culture. Stop micromanaging, start empowering!

In the seventh video of our series on creating company culture in a virtual environment, explore the essential leadership shift from process control to outcome control in remote work settings. Learn how this approach can enhance productivity and employee empowerment.

7. Learn the Difference Between Outcome Control vs. Process Control
In the remote work era, the traditional concerns about productivity have shifted as leaders gain more experience and confidence in their teams. This is why it’s crucial for leaders to focus on outcome control rather than process control. With the blending of work life and home life, especially evident in 2020, employees may need to juggle home-schooling children, sharing office spaces with partners, and more. By prioritizing outcomes over the specifics of day-to-day processes, leaders can trust their teams to achieve their goals in the way that best suits their unique circumstances. This shift not only empowers employees but also streamlines productivity, making the transition to remote work more sustainable and effective for everyone involved.

For deeper insights and to learn from our experiences, visit our blog: https://www.impetusdigital.com/2020/11/03/top-10-tips-for-creating-company-culture/

Enhance your virtual meeting strategies with Impetus Digital:

Stay connected for more tips on remote work and trending Pharma Topics:

This content was provided by Impetus Digital

Company Details

 Latest Content from  Impetus Digital 

Top-5 Trends in Virtual KOL Engagement

Register now for one of our upcoming webinars (February 26-28)

Engaging with Different Perspectives – Top 10 Most Important Advisor Questions

In this quick clip, we highlight a vital tip from our 'Top 10 Most Important Advisor Questions' – essential for enhancing your virtual collaboration strategies in Pharma and Life Sciences....

Patient Advocate Engagement: A Customer Story

Learn how our client executed a series of 3 virtual touchpoints with 5 rare disease patient advocates to:- Develop a better understanding of the current treatment landscape and lived patient...

Tailored Marketing Strategies for Pharma – Top 10 Most Important Advisor Questions

In this video, we explore another crucial aspect of advisor questions when developing your virtual advisory board touchpoints – a key component for success in today's diverse healthcare landscape. 7....

Trends in Virtual Collaboration

Join us for a look at the top-5 emerging virtual collaboration trends...

Advisor Questions on Potential Data or Knowledge Gaps

As part of our top 10 most important advisor questions that every brand team should keep in mind when designing virtual advisory board touchpoints, here's another one to keep in...

On a journey to diverse, inclusive, and more efficient rare disease trials

Although orphan drugs represent a sizeable portion of new drug approvals, most rare diseases still lack effective treatment. Even more so than for other conditions, rare disease management contains large care...

Versatility! Top 10 benefits of virtual advisory boards

Here's another great tip on why the benefits of virtual advisory boards are superior to in-person and hybrid advisory boards. #10. Versatility! Another major advantage of using a virtual platform...

Clinical Trials Investigator and Patient Engagement Planning: A Customer Story

In the early lead-up to our client’s multi-center Rare Disease Phase 3 Clinical Trial, they first conducted an internal engagement planning Longitudinal Expert Engagement Plan™ (LEEP™) to conduct an informal...

New Playbook Alert: Virtual Patient Engagement

Authentic patient engagement and insight-gathering are becoming must-haves in Pharma. However, multiple obstacles remain before patient-centricity becomes more than a buzzword. In our latest playbook, we take a deep dive...